Product details
Commercial name | Canigen L |
Authorization number | 220052 |
Authorization status | Valida |
Authorization date | 15-03-2022 |
Authorization valid date | nelimitata |
Active substance | L. interrogans, serogrup canicola, L. interrogans, serogrup icterohaemorrhagiae |
Target species | câini |
Therapeutical action | Caini Imunoprofilaxia leptospirozei. |
Therapeutic group | Produse biologice |
Pharmaceutical form | liofilizat şi solvent pentru suspensie injectabilă |
Packaging | flacon x 1 ml |
Withdrawal period | Nu este cazul. |
Manufacturer | VIRBAC S.A., Franţa |
Licence owner | VIRBAC S.A., Franţa |
Romanian responsible company | ALTIUS SA |
Link to prospectus | click aici pentru a vizualiza prospectul |
Link to authorization | |
Notes | Autorizat prin DCP. |
Release Mode | Cu prescripţie |
Authorization variations | |||
I. Variatii care necesita evaluare (VRA): |
|||
Variation No. | Date | Variation type | Description |
1 | 17-06-2024 | G.I.18 | Alinierea informatiilor despre produs cu versiunea QRD 9.0, adica actualizarea majora a formatelor QRD, conform Regulamentului (UE) 2019/6, pentru produse medicinale veterinare introduse pe piata in conformitate cu Directiva 2001/82/CE, Directiva 2001/82/CE sau Regulamentul (CE) nr. 726 / 2004. |
Authorizations history | ||||
Commercial name | Authorization number | Authorization date | Authorization valid date | Authorization status |
Canigen L | 170204 | 21-09-2017 | 21-09-2022 | Anulata |